Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
I cannot count the number of times I have thought to myself, “If it were not for the PSA, you would no doubt be out there playing golf, skiing, biking, taking a grandchild to the park, or just enjoying life.” Living from one PSA to the next is a bad way to mark the passing of time.
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
ASCO provides answers to some of the most frequently asked questions about the Society's proposed pathway for Maintenance of Certification, in response to your insightful feedback.
As a physician and a mom, I'm doing what all human beings do every day: making decisions about my life, career, and relationships, and hoping for the best.
As we move forward in oncology, my hope is that we will see miraculous recoveries more often, guided not by chance but by a better understanding of cancer biology. The promise of precision medicine remains a real one that I firmly believe in.
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.
As oncologists, we are shaped and molded by our patients. December is a perfect time to reflect on our patients and ourselves, with the hope that we will be able to improve our future.
Survival rates for many types of cancers have continued to improve over the past several decades, contributing to a growing number of long-term cancer survivors. With longer survival, attention to the chronic and long-term adverse treatment effects has become increasingly important.
Writing a prescription is the easiest part of we do in clinic. The harder part is truly understanding the financial burden a cancer diagnosis inflicts on patients and their families.
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Many of the couples that I see in my practice grow closer after the diagnosis and treatment of cancer. But for others, the experience of serious illness exposes existing weak points in their relationship.
Since the U.S. presidential election I have spoken with family and friends, many of whom who did not vote as I had, and you know what, they are still the same people they were before the election.
When we are at the bedside, eye to eye with the patient and their families, we can do more than any website, journal, or even Dr. Google can to help our patients understand their cancer and their treatment.
Dr. Rita Saroufim, and Dr. Sarah Daouk, and I helped high school students put their science lessons into real-world context during a presentation on breast cancer awareness.
A medical clinic is not set up for those who take their time, and efficiency is important. But in the short time we have for each patient visit, we must make an effort to be truly present with that person.
Not everyone shares my view of what constitutes a good death, and I’ve come to realize that when a patient has a very different view of the end of life from mine, it can be very difficult to do what’s right.

Pages


Advertisement